Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer.
暂无分享,去创建一个
E. B. Butler | W. Grant | L. S. Carpenter | S. Woo | B. Teh | B S Teh | W Y Mai | B M Uhl | M E Augspurger | W H Grant | H H Lu | S Y Woo | L S Carpenter | J K Chiu | E B Butler | J. McGary | Hsin H. Lu | J. Chiu | B. Uhl | J McGary | L Dong | W. Mai | H. Lu | L. Dong | M. Augspurger | E. Butler | L. Carpenter | Shiao Y Woo | Lei Dong | Shiao Y. Woo | L. Dong | S. Woo
[1] A. W. Kemp,et al. Medical Uses of Statistics. , 1994 .
[2] G J Kutcher,et al. Three-dimensional conformal radiotherapy and dose escalation: where do we stand? , 1998, Seminars in radiation oncology.
[3] E. B. Butler,et al. Does the "peacock" have anything to do with radiotherapy? , 1994, International journal of radiation oncology, biology, physics.
[4] J. Purdy. Intensity-modulated radiation therapy. , 1996, International journal of radiation oncology, biology, physics.
[5] M van Herk,et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[6] Chantal Ginestet,et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment , 1997 .
[7] P. Scardino,et al. Intensity-modulated radiation therapy (IMRT) for localized prostate cancer: A comparison of peacock conformal treatment volumes and pathologic radical prostatectomy specimens , 1998 .
[8] M. Zelefsky,et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.
[9] P. Levendag,et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. , 1999, International journal of radiation oncology, biology, physics.
[10] G Starkschall,et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. , 1996, International journal of radiation oncology, biology, physics.
[11] K. Godfrey. Comparing the Means of Several Groups , 1985, Medical Uses of Statistics.
[12] D. Hussey. American Society for Therapeutic Radiology and Oncology , 2001 .
[13] E. B. Butler,et al. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. , 1999, The oncologist.
[14] P. Schellhammer,et al. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[16] B. Corn,et al. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. , 1999, Urology.
[17] W. Grant,et al. 2271 Intensity modulated radiotherapy (IMRT) for prostate cancer: Rectal mucosal sparing by dosimetric effect of a rectal balloon , 1999 .
[18] C. Yu,et al. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. , 2000, Medical physics.